Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 47335-756

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 47335-756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing lung function in liters over time in hours after dosing. It compares Albuterol, Ipratropium, and a combination of Ipratropium bromide and Albuterol sulfate inhalation solution, with measurements from 0 to 8 hours post-dose.*

FDA Label Image

Figure2 (Figure2)

An instructional line drawing showing the assembly of a respiratory inhalation device. One hand is holding the inhaler mouthpiece, and another hand is using a dropper to add liquid medication into the inhaler chamber. The image is step 1 of the preparation process.*

FDA Label Image

Figure3 (Figure3)

Instructional diagram showing hands assembling or using a respiratory inhalation device, likely related to Ipratropium Bromide and Albuterol Sulfate solution. One hand holds the inhalation device while the other hand inserts or attaches a component, demonstrating preparation steps.*

FDA Label Image

Figure4 (Figure4)

Instructional diagram showing two steps of using an inhalation solution device. The first panel depicts a person placing the mouthpiece in the mouth. The second panel shows the person using a spacer or holding chamber attached to the inhaler. Both images focus on proper technique for respiratory inhalation of the medication.*

FDA Label Image

Snowbox 1

Packaging label for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg/3 mg strength. The label indicates it is for oral inhalation only, provided as 30 x 3 mL sterile unit-dose vials (six pouches of five 3 mL vials each). Distributed by Sun Pharmaceutical Industries, Inc., the label includes usage instructions and storage information.*

FDA Label Image

Structure1 (Structure1)

Chemical structure diagram of the active ingredient Albuterol Sulfate, showing its molecular arrangement with hydroxyl groups and attached sulfate ions.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of ipratropium bromide hydrate, showing its molecular arrangement with nitrogen-containing bicyclic rings and phenyl group, indicating the bromide hydrate salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.